EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?

Muhammad Sameed; Zhou Meng; Ellen T Marciniak

doi:10.1183/20734735.0363-2018

EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?

Breathe (Sheff). 2019 Sep;15(3):244-246. doi: 10.1183/20734735.0363-2018.

Authors

Muhammad Sameed¹, Zhou Meng¹, Ellen T Marciniak^{1

2}

Affiliations

¹ Dept of Internal Medicine, University of Maryland Medical Center Midtown, Baltimore, MD, USA.
² Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, MD, USA.

Abstract

In the EOLIA trial, early use of ECMO did not significantly improve mortality at 60 days in patients with severe ARDS, but when used as a rescue modality ECMO might help improve survival http://bit.ly/2XOjwSE.